J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
ATC group of level 4 – chemical subgroup · in plain English: medicines against viruses, e.g. HIV or hepatitis
This site has the patient leaflet or the SPC of 40 medicines in this group and its subgroups.
- 34 prescription only (POM)
- 3 no longer supplied or not available
Place in the ATC classification
- J Antiinfectives for systemic use 1,393 medicines
- J05 Antivirals for systemic use 392 medicines
- J05A Direct acting antivirals 392 medicines
-
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors 40 medicines
- J05AB01 aciclovir 19 medicines
- J05AB06 ganciclovir 2 medicines
- J05AB09 famciclovir 7 medicines
- J05AB11 valaciclovir 7 medicines
- J05AB12 cidofovir 2 medicines
- J05AB14 valganciclovir 3 medicines
-
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors 40 medicines
- J05A Direct acting antivirals 392 medicines
- J05 Antivirals for systemic use 392 medicines
4 more subgroups have no medicine with a leaflet on this site.
Active substances in the group
- Aciclovir 19 medicines
- Cidofovir 2 medicines
- Famciclovir 7 medicines
- Ganciclovir 2 medicines
- Valaciclovir 7 medicines
- Valganciclovir 3 medicines
Medicines in the group and its subgroups
Other groups of the same level
- J05AD Phosphonic acid derivatives, direct acting antivirals 2 medicines
- J05AE Protease inhibitors, direct acting antivirals 75 medicines
- J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 82 medicines
- J05AG Non-nucleoside reverse transcriptase inhibitors 32 medicines
- J05AH Neuraminidase inhibitors, direct acting antivirals 14 medicines
- J05AJ Integrase Inhibitors, antiinfectives for systematic use 15 medicines
- J05AP Antivirals for treatment of HCV infections 25 medicines
- J05AR Antivirals for treatment of HIV infections, combinations 80 medicines
- J05AX Other antivirals 27 medicines
Other names of the ATC group
- Czech: J05AB Nukleosidy a nukleotidy, kromě inhibitorů reverzní transkriptázy
- French: J05AB nucléosides et nucléotides, inhibiteurs de la transcriptase reverse exclus
- German: J05AB Nukleoside und Nukleotide, exkl. Inhibitoren der Reversen Transkriptase
- Spanish: J05AB NUCLEOSIDOS/NUCLEOTIDOS EXCLUID.INHIBID.TRANSCRIPASA INVERSA
- German: J05AB Nukleoside und Nukleotide, exkl. Inhibitoren der Reversen Transkriptase
- Italian: J05AB NUCLEOSIDI E NUCLEOTIDI, ESCLUSI GLI INIBITORI DELLA TRANSCRITTASI INVERSA
- Polish: J05AB Nukleozydy i nukleotydy, z wyjątkiem inhibitorów odwrotnej transkryptazy
- Turkish: J05AB Nükleozitler ve nükleotitler hariç. ters transkriptaz inhibitörleri
- Portuguese (Brazil): J05AB Nucleosídeos e Nucleotídeos com exclusão dos inibidores da transcriptase reversa
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group J05AB
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.